Volume 9, Issue 7 2402263
Review

Intelligent Nanomaterials Design for Osteoarthritis Managements

Zhihao Chen

Zhihao Chen

The Key Laboratory of Advanced Interdisciplinary Studies, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 511436 China

School of Biomedical Engineering, Guangzhou Medical University, Guangzhou, 511436 China

Search for more papers by this author
Xuan Zheng

Xuan Zheng

School of Biomedical Engineering, Guangzhou Medical University, Guangzhou, 511436 China

Search for more papers by this author
Zhengzhi Mu

Zhengzhi Mu

Key Laboratory of Bionic Engineering, Ministry of Education, Jilin University, Changchun, 130022 China

Search for more papers by this author
Weijie Lu

Weijie Lu

The Key Laboratory of Advanced Interdisciplinary Studies, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 511436 China

Department of Orthopedics, Yanjiang Hospital, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 511436 China

Search for more papers by this author
Haiyuan Zhang

Haiyuan Zhang

The Key Laboratory of Advanced Interdisciplinary Studies, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 511436 China

School of Biomedical Engineering, Guangzhou Medical University, Guangzhou, 511436 China

Search for more papers by this author
Jiao Yan

Corresponding Author

Jiao Yan

The Key Laboratory of Advanced Interdisciplinary Studies, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 511436 China

School of Biomedical Engineering, Guangzhou Medical University, Guangzhou, 511436 China

E-mail: [email protected]

Search for more papers by this author
First published: 30 March 2025
Citations: 1

Abstract

Osteoarthritis (OA) is the most prevalent degenerative joint disorder, characterized by progressive joint degradation, pain, and diminished mobility, all of which collectively impair patients’ quality of life and escalate healthcare expenditures. Current treatment options are often inadequate due to limited efficacy, adverse side effects, and temporary symptom relief, underscoring the urgent need for more effective therapeutic strategies. Recent advancements in nanomaterials and nanomedicines offer promising solutions by improving drug bioavailability, reducing side effects and providing targeted therapeutic benefits. This review critically examines the pathogenesis of OA, highlights the limitations of existing treatments, and explores the latest innovations in intelligent nanomaterials design for OA therapy, with an emphasis on their engineered properties, therapeutic mechanisms, and translational potential in clinical application. By compiling recent findings, this work aims to inspire further exploration and innovation in nanomedicine, ultimately advancing the development of more effective and personalized OA therapies.

Conflict of Interest

The authors declare that they have no competing interests.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.